共 36 条
Vitamin D replacement ameliorates serum lipoprotein functions, adipokine profile and subclinical atherosclerosis in pre-menopausal women
被引:16
作者:
Greco, D.
[1
]
Kocyigit, D.
[2
,8
]
Adorni, M. P.
[3
]
Marchi, C.
[3
]
Ronda, N.
[3
]
Bernini, F.
[3
]
Gurses, K. M.
[4
,9
]
Canpinar, H.
[5
]
Guc, D.
[5
]
Oguz, S. H.
[6
]
Gurlek, A.
[6
]
Strazzella, A.
[7
]
Simonelli, S.
[7
]
Tokgozoglu, L.
[2
]
Zimetti, F.
[3
]
机构:
[1] Univ Parma, Biopharmanet Tec Ctr, Parma, Italy
[2] Hacettepe Univ, Fac Med, Dept Cardiol, Ankara, Turkey
[3] Univ Parma, Dept Food & Drug, Parco Area Sci 27-A, I-43124 Parma, Italy
[4] Univ Hlth Sci, Konya Training & Res Hosp, Dept Cardiol, Konya, Turkey
[5] Hacettepe Univ, Canc Inst, Dept Basic Oncol, Ankara, Turkey
[6] Hacettepe Univ, Fac Med, Dept Internal Med, Sect Endocrinol & Metab, Ankara, Turkey
[7] Univ Milan, Dipartimento Sci Farmacol & Biomol, Ctr E Grossi Paoletti, Milan, Italy
[8] Afyonkarahisar Dinar State Hosp, Cardiol Clin, Afyon, Turkey
[9] Adnan Menderes Univ, Fac Med, Dept Basic Med Sci, Aydin, Turkey
关键词:
Vitamin D;
HDL;
Cholesterol efflux capacity;
Macrophage;
Adiponectin;
Resistin;
Atherosclerosis;
HIGH-DENSITY-LIPOPROTEIN;
APOLIPOPROTEIN-A-I;
CHOLESTEROL EFFLUX;
D SUPPLEMENTATION;
D DEFICIENCY;
CAPACITY;
METABOLISM;
EXPRESSION;
MARKERS;
IMPACT;
D O I:
10.1016/j.numecd.2018.04.010
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Background and aims: Low vitamin D (vitD) has been linked to increased cardiovascular (CV) risk, but the effects of vitD supplementation are not clarified. We evaluated the impact of vitD normalization on HDL cholesterol efflux capacity (CEC), which inversely correlates with CV risk, the proatherogenic serum cholesterol loading capacity (CLC), adipokine profile and subclinical atherosclerosis. Methods and results: Healthy premenopausal women with vitD deficiency (n = 31) underwent supplementation. Subclinical atherosclerosis was evaluated by flow-mediated dilation (FMD), pulse wave velocity (PWV) and augmentation index (AIx), measured with standard techniques. HDL CEC and serum CLC were measured by a radioisotopic and fluorimetric assay, respectively. Malondialdehyde (MDA) in HDL was quantified by the TBARS assay. Pre-beta HDL was assessed by 2D-electrophoresis. Serum adipokines were measured by ELISA. VitD replacement restored normal levels of serum 25-hydroxyvitamin D (25OHD) and significantly improved FMD (+4%; p < 0.001), PWV (-4.1%: p < 0.001) and AIx (-16.1%; p < 0.001). Total CEC was significantly improved (+19.5%; p = 0.003), with a specific increase in the ABCA1-mediated CEC (+70.8%; p < 0.001). HDL-MDA slightly but significantly decreased (-9.6%; p = 0.027), while no difference was detected in pre-beta HDL. No change was observed in aqueous diffusion nor in the ABCG1-mediated CEC. Serum CLC was significantly reduced (-13.3%; p = 0.026). Levels of adiponectin were increased (+50.6%; p < 0.0001) and resistin levels were decreased ( -24.3%; p < 0.0001). After vitD replacement, an inverse relationship was found linking the ABCA1-mediated CEC with pre-beta HDL (r(2) = 0.346; p < 0.001) and resistin (r(2) = 0.220; p = 0.009). Conclusion: Our data support vitD supplementation for CV risk prevention. (C) 2018 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:822 / 829
页数:8
相关论文